A detailed history of Fishman Jay A LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Fishman Jay A LTD holds 3,841 shares of LLY stock, worth $2.9 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
3,841
Previous 3,661 4.92%
Holding current value
$2.9 Million
Previous $3.31 Million 2.66%
% of portfolio
0.34%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$772.14 - $960.02 $138,985 - $172,803
180 Added 4.92%
3,841 $3.4 Million
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $104 Million - $131 Million
-143,841 Reduced 97.52%
3,661 $3.31 Million
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $104 Million - $131 Million
143,611 Added 3690.85%
147,502 $134 Million
Q4 2023

Jan 24, 2024

BUY
$525.19 - $619.13 $26,259 - $30,956
50 Added 1.3%
3,891 $2.27 Million
Q2 2023

Aug 15, 2023

BUY
$350.74 - $468.98 $1.35 Million - $1.8 Million
3,841 New
3,841 $1.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fishman Jay A LTD Portfolio

Follow Fishman Jay A LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fishman Jay A LTD with notifications on news.